Subject: NIAID Grant To Study Cryptosporidium
Date: Published: 4/20/92 (16 lines)
Source: Wall Street Journal. Copyright Dow Jones & Co. Inc.

    Business Briefs

[5 lines irrelevant to AIDS omitted.  -- sysop]

    ImmuCell Corp., Portland, Maine, said it received a
 $50,000 grant from the National Institute of Allergy and
 Infectious Diseases for the study of immunotherapy of
 cryptosporidium infections in AIDS patients.

[This article is made available here by Dow Jones Co. for the
 personal and non-commercial use of callers to this bbs, in the
 hope that it will be of some help to those who are suffering
 from the disease and others who are seeking to help them.]